Clinimix 520 mg (l-Arginine SOLUTION) 520 MG

Clinimix 520 mg is an intravenous solution containing L-arginine, designed for nutritional support. This product is manufactured by Baxter Corporation in Canada and is available in a 1000ml pack size.

Strength

520 MG

Pack Size

1000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinimix 520 mg is primarily used for nutritional support in patients who require intravenous nutrition. L-arginine, a key component, is an amino acid that plays a role in various bodily functions. This solution is often used in clinical settings to provide essential nutrients to patients who cannot consume food orally.

Side Effects

When administered intravenously, Clinimix 520 mg provides essential nutrients directly into the bloodstream. L-arginine can support various metabolic processes, including protein synthesis and immune function. Patients may experience improved nutritional status and overall well-being with regular use.

Precautions & Warnings

Clinimix 520 mg should be administered under medical supervision. It is important to follow proper handling and storage guidelines to maintain the integrity of the solution. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

Clinimix 520 mg may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Additionally, certain medical conditions may affect the suitability of this solution, so always consult a healthcare professional.

Frequently Asked Questions

Clinimix 520 mg is used for nutritional support in patients who require intravenous nutrition, particularly those who cannot consume food orally.

Clinimix 520 mg is administered intravenously, typically in a clinical setting under medical supervision.

Clinimix 520 mg provides essential nutrients directly into the bloodstream, supporting metabolic processes and overall well-being.

Yes, Clinimix 520 mg should be administered under medical supervision, and proper handling and storage guidelines should be followed.

Yes, Clinimix 520 mg may interact with other medications or supplements, so it is important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.